CKMH Overweight / Obesity

My Settings
Relevant Content
Comprehensive Clinical Approach to Cardiovascular Kidney Metabolic Syndrome
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy
Polypharmacy is common in cardiovascular (CV) care because guideline-direc...
Cardiovascular Risk Reduction With GLP-1 RA Drugs
Circulation, Volume 154, Issue 1, Page 66-73, July 7, 2026.
GLP-1 (gl...
Researchers at Heart
Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance
Circulation: Population Health and Outcomes, Ahead of Print.
BACKGROU...
Strategies for Optimizing Heart Failure Care in the Older Adult
Heart failure (HF) in older adults is a growing and distinct clinical chal...
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease
The American Heart Association Predicting Risk of Cardiovascular Disease E...
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
Guideline offering updated evidence on cardiovascular‑kidney‑metabolic syn...
Lifestyle-Induced Visceral Fat Loss as a Key Target for Durable Cardiometabolic Health: MRI-Assessed 5- and 10-Year Follow-Up After 2 Clinical Trials
Circulation, Ahead of Print.
BACKGROUND:During the 18-month CENTRAL (...
Incretin-Based Therapies and Cardiovascular Outcomes: Beyond Weight Loss
Circulation, Volume 153, Issue 20, Page 1523-1525, May 19, 2026.